BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34662351)

  • 1. Human genital antibody-mediated inhibition of Chlamydia trachomatis infection and evidence for ompA genotype-specific neutralization.
    Ardizzone CM; Albritton HL; Lillis RA; Bagnetto CEL; Shen L; Cavacini LA; Kozlowski PA; Quayle AJ
    PLoS One; 2021; 16(10):e0258759. PubMed ID: 34662351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments.
    Albritton HL; Kozlowski PA; Lillis RA; McGowin CL; Siren JD; Taylor SN; Ibana JA; Buckner LR; Shen L; Quayle AJ
    PLoS One; 2017; 12(8):e0183101. PubMed ID: 28797112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three commercially available peptide-based immunoglobulin G (IgG) and IgA assays to microimmunofluorescence assay for detection of Chlamydia trachomatis antibodies.
    Morré SA; Munk C; Persson K; Krüger-Kjaer S; van Dijk R; Meijer CJ; van Den Brule AJ
    J Clin Microbiol; 2002 Feb; 40(2):584-7. PubMed ID: 11825974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune response to membrane components of Chlamydia trachomatis and expression of human 60 kDa heat shock protein in follicular fluid of in-vitro fertilization patients.
    Neuer A; Lam KN; Tiller FW; Kiesel L; Witkin SS
    Hum Reprod; 1997 May; 12(5):925-9. PubMed ID: 9194641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between an asymptomatic male genital tract exposure to Chlamydia trachomatis and an autoimmune response to spermatozoa.
    Witkin SS; Kligman I; Bongiovanni AM
    Hum Reprod; 1995 Nov; 10(11):2952-5. PubMed ID: 8747052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and follow-up of genital chlamydial infection by direct methods and by detection of serum IgG, IgA and secretory IgA.
    Fresse AS; Sueur JM; Hamdad F
    Indian J Med Microbiol; 2010; 28(4):326-31. PubMed ID: 20966563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H; Parnell M; Caldwell HD
    Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
    Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
    Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection.
    Ficarra M; Ibana JS; Poretta C; Ma L; Myers L; Taylor SN; Greene S; Smith B; Hagensee M; Martin DH; Quayle AJ
    Am J Reprod Immunol; 2008 Nov; 60(5):415-25. PubMed ID: 18798835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic antibody response to
    Gupta VK; Waugh CA; Ziklo N; Huston WM; Hocking JS; Timms P
    Indian J Med Microbiol; 2017; 35(3):394-401. PubMed ID: 29063885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis OmpA genotyping as a tool for studying the natural history of genital chlamydial infection.
    Geisler WM; Black CM; Bandea CI; Morrison SG
    Sex Transm Infect; 2008 Dec; 84(7):541-4; discussion 544-5. PubMed ID: 18708486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
    Peterson EM; Cheng X; Motin VL; de la Maza LM
    Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
    Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L
    Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Variable Domain 4 Linear Epitopes of the
    Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007
    [No Abstract]   [Full Text] [Related]  

  • 16. Class specific immunoglobulin response to individual polypeptides of Chlamydia trachomatis, elementary bodies, and reticulate bodies in patients with chlamydial infection.
    Cevenini R; Rumpianesi F; Donati M; Moroni A; Sambri V; La Placa M
    J Clin Pathol; 1986 Dec; 39(12):1313-6. PubMed ID: 3805317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to chlamydia trachomatis in semen and relationship with parameters of male fertility.
    Eggert-Kruse W; Buhlinger-Gopfarth N; Rohr G; Probst S; Aufenanger J; Naher H; Runnebaum B
    Hum Reprod; 1996 Jul; 11(7):1408-17. PubMed ID: 8671477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection.
    Berry LJ; Hickey DK; Skelding KA; Bao S; Rendina AM; Hansbro PM; Gockel CM; Beagley KW
    Infect Immun; 2004 Feb; 72(2):1019-28. PubMed ID: 14742549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera.
    Lampe MF; Wong KG; Kuehl LM; Stamm WE
    Infect Immun; 1997 Jan; 65(1):317-9. PubMed ID: 8975931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlamydia trachomatis species specific serology: ImmunoComb Chlamydia bivalent versus microimmunofluorescence (MIF).
    Clad A; Freidank H; Plünnecke J; Jung B; Petersen EE
    Infection; 1994; 22(3):165-73. PubMed ID: 7927811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.